Lactoferrin in Primate and Mouse Models of Asthma

Award Information
Agency:
Department of Health and Human Services
Branch
n/a
Amount:
$99,925.00
Award Year:
2004
Program:
SBIR
Phase:
Phase I
Contract:
1R43AI058553-01
Agency Tracking Number:
AI058553
Solicitation Year:
2004
Solicitation Topic Code:
n/a
Solicitation Number:
PHS2004-2
Small Business Information
AGENNIX, INC.
AGENNIX, INC., 8 GREENWAY PLZ, STE 910, HOUSTON, TX, 77046
Hubzone Owned:
N
Socially and Economically Disadvantaged:
N
Woman Owned:
N
Duns:
n/a
Principal Investigator:
ATUL Varadhachary
(713) 552-1091
AVARADHACHARY@AGENNIX.COM
Business Contact:
RICK BARSKY
(713) 552-1091
RBARSKY@AGENNIX.COM
Research Institution:
n/a
Abstract
DESCRIPTION (provided by applicant): The purpose of this research is to extend work to determine the efficacy of orally administered recombinant human lactoferrin (rhLF) in an established primate model of asthma. Asthma is one of the most prevalent chr

* information listed above is at the time of submission.

Agency Micro-sites

US Flag An Official Website of the United States Government